Head and neck cancers (HNC) represent the seventh most frequent cancer worldwide, with
squamous cell carcinomas as the most frequent histologic subtype. Standard treatment for …

Head and neck cancer (HNC) is a term collectively used to describe a heterogeneous group
of tumors that arise in the oral cavity, larynx, nasopharynx, oropharynx, and hypopharynx …

Simple Summary Next-generation sequencing of head and neck squamous cell carcinoma
has revealed multiple new gene mutations, while simultaneously confirming the role of …

Overexpression of the epidermal growth factor receptor (EGFR) in head and neck squamous
cell carcinomas (HNSCC) is considered to cause increased EGFR activity, which adds to …

The prevalence and prognostic value of human papillomavirus (HPV) infection and
epidermal growth factor receptor (EGFR) alteration in sinonasal squamous cell carcinoma …

Simple Summary Cancers in the head and neck region are often aggressive and poorly
respond to both irradiation or chemotherapy. Chemotherapy is currently limited by a small …

Sinonasal squamous cell carcinoma (SNSCC) is sometimes associated with high-risk
human papillomavirus (HR-HPV) infection and inverted sinonasal papilloma or oncocytic …

Since its introduction, the use of cetuximab in the treatment of head and neck squamous cell
carcinoma (HNSCC) has experienced an evolution. Currently, cetuximab associated with …

Aims The aim of this systematic literature review was to provide updated information on
human papillomavirus (HPV) prevalence in locally and regionally advanced (LA) and …

Head and neck cancer (HNC), the sixth most common cancer worldwide, is increasing in
incidence, with oral squamous cell carcinoma (OSCC) as the predominant subtype. OSCC …